The Kansas State Legislature has appropriated funding that supports many ongoing stem cell-related research projects. In addition, examples of other funding sources are listed below.
NSF DMR – 1242765 Dual PI (Stefan Bossmann and Deryl Troyer)
CREATIV: Neutrophil delivery of apoptosis-inducing drugs.
NSF CBET 1159966 Dual PI (Stefan Bossmann and Deryl Troyer)
Extending the luminescence lifetime in breast cancer diagnostics
NSF-CBET 933701 Dual PI (Stefan Bossmann and Deryl Troyer): Renilla Transfected stem cells as light source for In-Situ Photodynamic Therapy of Cancer. 1/01/10-12/31/12
NIH CHHSN26100800059C Phase II from the Small Business Innovation Research Development Center (SBIR) of the National Cancer Institute. Kroh F, NanoScale Corp., PI; Bossmann S Co-PI, Troyer D, Co-PI, Gadbury G, Co-PI. Low-Toxicity Nanomaterials for treatment and detection of cancer. 01/01/11-12/31/12
USDA Davis D (PI), Troyer D (Co-PI), Grieger D (Co-PI): "Stem cells and pluripotency in farm animals" USDA HATCH #KS413, 10/01/08-9/30/13.
Legislative Appropriation Troyer D (PI), Davis D (PI), Weiss M (PI): Postnatal stem cells derived from Wharton's Jelly of the umbilical cord. Kansas State Legislative Appropriation, 7/1/06-present.
Bioscience Authority (Collaborative Cancer Research Initiative; CCRI). Tamura M (PI); Troyer D (Co-PI); Weiss M (Collaborator); Marini F (Collaborator): Umbilical cord matrix stem cell-based gene therapy for pancreatic cancer. 12/31/09-12/30/11.
NIH P20 RRO16475 Troyer D, PI
Novel paradigm using monocytes with magnetic nanoparticles and Sn-38 in melanoma. 5/01/2010-4/30/2012.
NSF STTR Bossman S (PI), Chikan V (Co-PI), Troyer D (Co-PI): Intelligent low toxicity materials for cancer diagnosis and treatment. NanoScale Coporation (NSF phase I STTR and Kansas Bioscience Authority flowdown) 7/01-09-6/30/10.
NIH COBRE Tamura M (PI), Troyer D (Co-Invest), Nanoparticle-based dual gene therapy for lung adenocarcinoma. NIH P20 RR015563,National Center for Research Resources, University of Kansas Experimental Therapeutics COBRE, 10/01/08-9/30/2010
NIH R21 Troyer D (PI), Tamura M (Co-Invest), Hua D (Co-Invest): Stem cells as vehicles for therapeutic nanoparticle delivery to breast cancer. NIH 1R21CA135599. 5/1/2008-4/30/2010